HVIPs
…e to violence. Hospital-based violence intervention programmes (HVIPs) can reduce patients’ exposure to violence but can place additi…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 359 of 2459ReNU syndromeRNU4-2epilepsydevelopmental delay
…y, epilepsy, short stature and distinctive dysmorphic features. ReNU syndrome accounts for 0.4–0.5% of all cases of developmental delay, and …
ravulizumabcrovalimabparoxysmal nocturnal haemoglobinuriaeculizumabNational Institute for Health and Care ExcellenceNICE
…bability of non-inferiority of crovalimab versus eculizumab and ravulizumab.Conclusions Interpretations of statistically non-significant IT…
multiple sclerosisiStep-MSMSMS-impactMS-related
… limiting sedentary behaviour are important aspects in managing multiple sclerosis (MS). Fatigue is a common and disabling symptom in MS, contribu…
Medtronic NeurovascularStryker Neurovascularballoon angioplastyRapid Medical
…. Hamilton: None. F. Laghari: None. N. Beaty: 6; C; proctor for Medtronic Neurovascular, Stryker Neurovascular, and CMO of NeuroMedica. G. Colby: 2; C;…
chronic subdural hematoma (cSDH)cSDHOnyxn-BCAPVA
…ingeal artery embolization (MMAe) is increasingly used to treat chronic subdural hematoma (cSDH). Both particle and liquid embolic agents are used in practice. …
intracranial aneurysmsclippingcoilingunruptured intracranial aneurysmFDNIS
…Background Women harbor intracranial aneurysms at higher prevalence than men and may demonstrate distinct aneu…
Tigertrieveracute ischemic strokeCochraneEmbaseClinicalTrials.govPubMedMechanical thrombectomylarge vessel occlusions
…ertainty for different outcomes was overall moderate.Conclusion Tigertriever was associated with significantly higher reperfusion rates, wit…
MedicareAneurysmal subarachnoid hemorrhageendovascular therapyNational Inpatient SampleaSAHendovascular treatment
…pping. Insurance status demonstrated modality-specific effects: Medicare insurance was associated with increased mortality and complicat…
strokeChronic Kidney DiseaseCKDCDC WONDER
… targeted risk reduction strategies.Highlights • CKD-associated stroke mortality declined from 1999-2009, increased transiently, then …
cSDHanticoagulantschronic subdural hematomas (cSDH)SEPSMedtronicMMAEMiddle meningeal artery embolizationantiplatelet agents
…eview was performed to identify studies evaluating treatment of cSDH using SEPS alone or in combination with MMAE. Searches were con…